"CD4-CD8 Ratio" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Ratio of T-LYMPHOCYTES that express the CD4 ANTIGEN to those that express the CD8 ANTIGEN. This value is commonly assessed in the diagnosis and staging of diseases affecting the IMMUNE SYSTEM including HIV INFECTIONS.
| Descriptor ID |
D016516
|
| MeSH Number(s) |
E01.370.225.500.195.107.595.500.150.160 E01.370.225.625.107.595.500.150.160 E05.200.500.195.107.595.500.150.160 E05.200.625.107.595.500.150.160 E05.242.195.107.595.500.150.160 G04.140.107.595.500.150.160 G09.188.105.595.500.150.160 G12.248
|
| Concept/Terms |
CD4-CD8 Ratio- CD4-CD8 Ratio
- CD4 CD8 Ratio
- CD4-CD8 Ratios
- T4-T8 Ratio
- T4 T8 Ratio
- T4-T8 Ratios
|
Below are MeSH descriptors whose meaning is more general than "CD4-CD8 Ratio".
Below are MeSH descriptors whose meaning is more specific than "CD4-CD8 Ratio".
This graph shows the total number of publications written about "CD4-CD8 Ratio" by people in this website by year, and whether "CD4-CD8 Ratio" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "CD4-CD8 Ratio" by people in Profiles.
-
CYP2B6 516 G>T polymorphism and side effects of the central nervous system in HIV-positive individuals under Efavirenz treatment: Study of a sample from southern Brazil. An Acad Bras Cienc. 2017 May; 89(1 Suppl?0):497-504.
-
TCR-Vbeta flow cytometric analysis of peripheral blood for assessing clonality and disease burden in patients with T cell large granular lymphocyte leukaemia. J Clin Pathol. 2010 Feb; 63(2):141-6.
-
Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma. Invest Ophthalmol Vis Sci. 2007 Jun; 48(6):2553-60.
-
Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen. Cancer. 2005 Jul 15; 104(2):345-53.
-
Neonatal dexamethasone treatment induces long-lasting changes in T-cell receptor vbeta repertoire in rats. J Neuroimmunol. 2001 Jan 01; 112(1-2):47-54.
-
Alterations in HIV expression in AIDS patients with psoriasis or pruritus treated with phototherapy. J Am Acad Dermatol. 1999 Jan; 40(1):48-60.
-
Effects of neonatal dexamethasone treatment on hypothalamo-pituitary adrenal axis and immune system of the rat. J Neuroimmunol. 1997 Apr; 74(1-2):69-76.
-
Selective depletion of CD8+ cells for prevention of graft-versus-host disease after bone marrow transplantation. A randomized controlled trial. Transplantation. 1994 Jan; 57(1):82-7.
-
Phase II study of deoxyspergualin in metastatic breast cancer. Invest New Drugs. 1994; 12(3):235-41.
-
A phase-I clinical study of low-dose oral interferon-alpha. J Immunother Emphasis Tumor Immunol. 1993 Jul; 14(1):51-5.